These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


306 related items for PubMed ID: 8944338

  • 1. Skin tumors in photochemotherapy for psoriasis: a single-center follow-up of 496 patients.
    Maier H, Schemper M, Ortel B, Binder M, Tanew A, Hönigsmann H.
    Dermatology; 1996; 193(3):185-91. PubMed ID: 8944338
    [Abstract] [Full Text] [Related]

  • 2. Skin carcinomas and treatment with photochemotherapy (PUVA).
    Lindskov R.
    Acta Derm Venereol; 1983; 63(3):223-6. PubMed ID: 6192635
    [Abstract] [Full Text] [Related]

  • 3. The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy Follow-up Study.
    Stern RS, Laird N.
    Cancer; 1994 Jun 01; 73(11):2759-64. PubMed ID: 8194017
    [Abstract] [Full Text] [Related]

  • 4. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group.
    Karagas MR, McDonald JA, Greenberg ER, Stukel TA, Weiss JE, Baron JA, Stevens MM.
    J Natl Cancer Inst; 1996 Dec 18; 88(24):1848-53. PubMed ID: 8961975
    [Abstract] [Full Text] [Related]

  • 5. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
    Archier E, Devaux S, Castela E, Gallini A, Aubin F, Le Maître M, Aractingi S, Bachelez H, Cribier B, Joly P, Jullien D, Misery L, Paul C, Ortonne JP, Richard MA.
    J Eur Acad Dermatol Venereol; 2012 May 18; 26 Suppl 3():22-31. PubMed ID: 22512677
    [Abstract] [Full Text] [Related]

  • 6. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.
    Stern RS, Liebman EJ, Väkevä L.
    J Natl Cancer Inst; 1998 Sep 02; 90(17):1278-84. PubMed ID: 9731734
    [Abstract] [Full Text] [Related]

  • 7. Widespread cutaneous carcinomas associated with human papillomaviruses 5, 14 and 20 after introduction of methotrexate in two long-term PUVA-treated patients.
    Zumtobel U, Schwarze HP, Favre M, Taïeb A, Delaunay M.
    Dermatology; 2001 Sep 02; 202(2):127-30. PubMed ID: 11306834
    [Abstract] [Full Text] [Related]

  • 8. Nonmelanoma skin tumors in long-term photochemotherapy treatment of psoriasis. An 8-year follow-up study.
    Tanew A, Hönigsmann H, Ortel B, Zussner C, Wolff K.
    J Am Acad Dermatol; 1986 Nov 02; 15(5 Pt 1):960-5. PubMed ID: 3782536
    [Abstract] [Full Text] [Related]

  • 9. Skin cancer in the PUVA-48 cooperative study.
    Roenigk HH, Caro WA.
    J Am Acad Dermatol; 1981 Mar 02; 4(3):319-24. PubMed ID: 7217399
    [Abstract] [Full Text] [Related]

  • 10. Long-term follow-up of skin cancer in the PUVA-48 cooperative study.
    Forman AB, Roenigk HH, Caro WA, Magid ML.
    Arch Dermatol; 1989 Apr 02; 125(4):515-9. PubMed ID: 2649011
    [Abstract] [Full Text] [Related]

  • 11. High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients.
    Lim JL, Stern RS.
    J Invest Dermatol; 2005 Mar 02; 124(3):505-13. PubMed ID: 15737190
    [Abstract] [Full Text] [Related]

  • 12. Skin cancers or premalignant lesions occur in half of high-dose PUVA patients.
    Lever LR, Farr PM.
    Br J Dermatol; 1994 Aug 02; 131(2):215-9. PubMed ID: 7917985
    [Abstract] [Full Text] [Related]

  • 13. UV dose determines key characteristics of nonmelanoma skin cancer.
    Ramos J, Villa J, Ruiz A, Armstrong R, Matta J.
    Cancer Epidemiol Biomarkers Prev; 2004 Dec 02; 13(12):2006-11. PubMed ID: 15598755
    [Abstract] [Full Text] [Related]

  • 14. 'High single-dose' European PUVA regimen also causes an excess of non-melanoma skin cancer.
    Bruynzeel I, Bergman W, Hartevelt HM, Kenter CC, Van de Velde EA, Schothorst AA, Suurmond D.
    Br J Dermatol; 1991 Jan 02; 124(1):49-55. PubMed ID: 1993145
    [Abstract] [Full Text] [Related]

  • 15. Cutaneous carcinoma and 8-methoxypsoralen and ultraviolet A (PUVA) lentigines in Japanese patients with psoriasis treated with topical PUVA: a follow-up study of 214 patients.
    Takashima A, Matsunami E, Yamamoto K, Kitajima S, Mizuno N.
    Photodermatol Photoimmunol Photomed; 1990 Oct 02; 7(5):218-21. PubMed ID: 2091746
    [Abstract] [Full Text] [Related]

  • 16. PUVA and cancer: a case-control study.
    Lindelöf B, Sigurgeirsson B.
    Br J Dermatol; 1993 Jul 02; 129(1):39-41. PubMed ID: 8369208
    [Abstract] [Full Text] [Related]

  • 17. Risks of cancer associated with long-term exposure to PUVA in humans: current status--1991.
    Stern RS.
    Blood Cells; 1992 Jul 02; 18(1):91-7; discussion 98-9. PubMed ID: 1617196
    [Abstract] [Full Text] [Related]

  • 18. High mutation frequency at Ha-ras exons 1-4 in squamous cell carcinomas from PUVA-treated psoriasis patients.
    Kreimer-Erlacher H, Seidl H, Bäck B, Kerl H, Wolf P.
    Photochem Photobiol; 2001 Aug 02; 74(2):323-30. PubMed ID: 11547572
    [Abstract] [Full Text] [Related]

  • 19. Bowen's disease and squamous cell carcinoma. Occurrence in a patient with psoriasis after topical, systemic, and PUVA therapy.
    Tam DW, Van Scott EJ, Urbach F.
    Arch Dermatol; 1979 Feb 02; 115(2):203-4. PubMed ID: 426530
    [Abstract] [Full Text] [Related]

  • 20. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study.
    Stern RS, PUVA Follow-Up Study.
    J Am Acad Dermatol; 2012 Apr 02; 66(4):553-62. PubMed ID: 22264671
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.